Join the Inbrija group to help and get support from people like you.
Inbrija News
AAN: Tavapadon as Adjunct to Levodopa Ups Daily ON Time in Parkinson Disease
TUESDAY, April 8, 2025 – For patients with Parkinson disease with motor fluctuations, the oral once-daily, selective D1/D5 partial dopamine agonist tavapadon as an adjunct to levodopa increases...
Early Research Points to Possible New Parkinson's Drug
THURSDAY, Dec. 19, 2024 – Parkinson's is a relentless disease for which few treatments, and no real cure, exists. Now, researchers say they are on the trail of a potential new therapy for the...
FDA Approves Inbrija (levodopa inhalation powder) for Intermittent Treatment of OFF Episodes in People with Parkinson’s Disease
ARDSLEY, N.Y.--(BUSINESS WIRE) December 21, 2018 --Acorda Therapeutics, Inc. today announced that the U.S. Food and Drug Administration approved Inbrija™ for intermittent treatment of OFF episodes in ...